Comparative bioavailability of two acebutolol formulations. 1978

R Verbesselt, and T B Tjandramaga, and A Mullie, and P J De Schepper

UI MeSH Term Description Entries
D008297 Male Males
D002214 Capsules Hard or soft soluble containers used for the oral administration of medicine. Capsule,Microcapsule,Microcapsules
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000070 Acebutolol A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action. Acebutolol Hydrochloride,Acetobutolol,Apo-Acebutolol,M & B 17803A,M&B-17803 A,Monitan,Neptal,Novo-Acebutolol,Prent,Rhotral,Sectral,Apo Acebutolol,ApoAcebutolol,M&B 17803 A,M&B17803 A,Novo Acebutolol,NovoAcebutolol
D000107 Acetylation Formation of an acetyl derivative. (Stedman, 25th ed) Acetylations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D013607 Tablets Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. (Dorland, 28th ed) Tablet

Related Publications

R Verbesselt, and T B Tjandramaga, and A Mullie, and P J De Schepper
June 2000, The Journal of the Association of Physicians of India,
R Verbesselt, and T B Tjandramaga, and A Mullie, and P J De Schepper
October 2009, International journal of clinical pharmacology and therapeutics,
R Verbesselt, and T B Tjandramaga, and A Mullie, and P J De Schepper
January 2003, Proceedings of the Western Pharmacology Society,
R Verbesselt, and T B Tjandramaga, and A Mullie, and P J De Schepper
January 2009, Proceedings of the Western Pharmacology Society,
R Verbesselt, and T B Tjandramaga, and A Mullie, and P J De Schepper
January 2006, Biopharmaceutics & drug disposition,
R Verbesselt, and T B Tjandramaga, and A Mullie, and P J De Schepper
May 1995, International journal of clinical pharmacology and therapeutics,
R Verbesselt, and T B Tjandramaga, and A Mullie, and P J De Schepper
April 1984, Journal of pharmaceutical sciences,
R Verbesselt, and T B Tjandramaga, and A Mullie, and P J De Schepper
March 1995, International journal of clinical pharmacology and therapeutics,
R Verbesselt, and T B Tjandramaga, and A Mullie, and P J De Schepper
August 1997, International journal of clinical pharmacology and therapeutics,
R Verbesselt, and T B Tjandramaga, and A Mullie, and P J De Schepper
January 2004, Journal of immunoassay & immunochemistry,
Copied contents to your clipboard!